Adrian Adams

2020 - IMPEL PHARMACEUTICALS

In 2020, Adrian Adams earned a total compensation of $3.7M as Chief Executive Officer and President at IMPEL PHARMACEUTICALS.

Compensation breakdown

Non-Equity Incentive Plan$95,544
Option Awards$3,348,910
Salary$266,041
Other$15,330
Total$3,725,825

Adams received $3.3M in option awards, accounting for 90% of the total pay in 2020.

Adams also received $95.5K in non-equity incentive plan, $266K in salary and $15.3K in other compensation.

Rankings

In 2020, Adrian Adams' compensation ranked 3,102nd out of 13,090 executives tracked by ExecPay. In other words, Adams earned more than 76.3% of executives.

ClassificationRankingPercentile
All
3,102
out of 13,090
76th
Division
Manufacturing
1,207
out of 5,621
79th
Major group
Chemicals And Allied Products
460
out of 2,254
80th
Industry group
Drugs
398
out of 1,954
80th
Industry
Pharmaceutical Preparations
297
out of 1,459
80th
Source: SEC filing on April 26, 2022.

Adams' colleagues

We found one more compensation record of an executive who worked with Adrian Adams at IMPEL PHARMACEUTICALS in 2020.

2020

John Leaman

IMPEL PHARMACEUTICALS

Chief Financial & Business Officer

News

In-depth

You may also like